Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · Real-Time Price · USD
1.730
+0.540 (45.38%)
May 26, 2026, 12:26 PM EDT - Market open
Artelo Biosciences Market Cap
Artelo Biosciences has a market cap or net worth of $1.62 million as of May 26, 2026. Its market cap has decreased by -50.53% in one year.
Market Cap
1.62M
Enterprise Value
-8.44M
1-Year Change
-50.53%
Ranking
Category
Stock Price
$1.73
Market Cap Chart
Since November 14, 2017, Artelo Biosciences's market cap has decreased from $5.88M to $1.62M, a decrease of -72.38%. That is a compound annual growth rate of -14.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 1.12M | -54.67% |
| Dec 31, 2025 | 2.46M | -28.01% |
| Dec 31, 2024 | 3.42M | -23.37% |
| Dec 29, 2023 | 4.46M | -45.90% |
| Dec 30, 2022 | 8.25M | -62.41% |
| Dec 31, 2021 | 21.95M | 99.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 14, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Valion Bio | 2.68M |
| Oragenics | 2.59M |
| SciSparc | 2.41M |
| Clearmind Medicine | 2.30M |
| Bone Biologics | 2.19M |
| Biodexa Pharmaceuticals | 2.13M |
| Silexion Therapeutics | 2.09M |
| Scinai Immunotherapeutics | 1.83M |